COVID-19 Effects on Glycemic Control in Diabetics Compared to Healthy Individuals

Authors

  • Zahra Moradi, Mostafa Tohidian, Zahra Movahednia, Fatemeh Mahmoudikohani, Susan Samimi, Mostafa Moazamfard, Sheida Jamalnia, Hamid Behrouj

Abstract

Background: numerous studies have reported that COVID-19 can affect various organs and tissues in the body, including the pancreas. This study aimed to evaluate the effect of COVID-19 on fasting blood glucose, hemoglobin A1c, and insulin in COVID-19 infected patients.

Methods: Three hundred patients with positive SARS-CoV-2 real-time PCR tests were included in the study. Based on their fasting blood glucose and hemoglobin A1c status they were divided into normoglycemic, prediabetic, and diabetic groups. Fasting blood glucose, hemoglobin A1c, and fasting insulin levels were measured during and three months after COVID-19 infection.

Results: there were no statistically significant differences between fasting blood glucose, hemoglobin A1c, and fasting insulin levels during and three months after COVID-19 infection between all study groups.

Conclusion:despite conflicting previous reports, the present study results suggest that COVID-19 infection can not interfere with glycemic control and related markers.

Downloads

Published

2022-04-11

Issue

Vol. 37 No. 3 (2022): Volume 37 Number 3 Year 2022

Section

Articles